Headlight LED 2Pcs Hi/Low 2005-2012 GT Mustang Ford For Bulbs Blue ICE 8000K Kit Car & Truck LED Light Bulbs


  1. Home
  2. Headlight LED 2Pcs Hi/Low 2005-2012 GT Mustang Ford For Bulbs Blue ICE 8000K Kit
  1. facebook
  2. twitter
  3. linkedin
  4. pinterest
2Pcs LED Headlight Hi/Low Kit 8000K ICE Blue Bulbs For Ford Mustang GT 2005-2012
Condition: New Brand:

SHENKENUO

UPC:

Does not apply

Manufacturer Part Number:

Does Not Apply

EAN:

Does not apply

Placement on Vehicle: Front, Left, Right
Color:

Ice Blue

Warranty: 1 Year
MPN:

H13 BLUE

Fitment Type: Direct Replacement
Bulb Type: LED Type: Headlight Kit
LED String/Strip Type: Does not apply Ballast Included: No
Beam Type: High or Low Beam / DUAL BEAM Number of Bulbs: 2
Certifications: CE / Rohs / IP68 Waterproof Bulb Size: H13 (9008)
Lumens (Light Flux): 16000LM Color Temperature: 8000K
Light Color: Ice BLUE Voltage: 12V
Bundle Listing: Yes To Fit: Headlight










published on tue nov 09 2021

Headlight LED 2Pcs Hi/Low 2005-2012 GT Mustang Ford For Bulbs Blue ICE 8000K Kit Car & Truck LED Light Bulbs

gandhi, s., klein, j., robertson, a., pena-hernandez, m. a.,

Headlight LED 2Pcs Hi/Low 2005-2012 GT Mustang Ford For Bulbs Blue ICE 8000K Kit Car & Truck LED Light Bulbs

lin, m. j., roychoudhury, p., lu, p., fournier, j., ferguson, d., mohamed bakhash, s. a., muenker, m. c., srivathsan, a., wunder, e. a., kerantzas, n., wang, w., pyle, a., wilen, c. b., ogbuagu, o., greninger ,, a. l., iwasaki, a., schulz, w. l., ko, a. i.

sars-cov-2 remdesivir resistance mutations have been generated in vitro but have not been reported in patients receiving treatment with the antiviral agent. we present a case of an immunocompromised patient with acquired b-cell deficiency who developed an indolent, protracted course of sars-cov-2 infection. remdesivir therapy alleviated symptoms and produced a transient virologic response, but her course was complicated by recrudescence of high-grade viral shedding. whole genome sequencing identified a mutation, e802d, in the nsp12 rna-dependent rna polymerase which was not present in pre-treatment specimens. in vitro experiments demonstrated that the mutation conferred a ~6-fold increase in remdesivir ic50 but resulted in a fitness cost in the absence of remdesivir. sustained clinical and virologic response was achieved after treatment with casirivimab-imdevimab. although the fitness cost observed in vitro may limit the risk posed by e802d,

, this case illustrates the importance of monitoring for remdesivir resistance and the potential benefit of combinatorial therapies in immunocompromised patients with sars-cov-2 infection.

509
1.2k
EVGENIA.RU RSS